Minimally Invasive Surgical Instruments Market


                

According to the Global Cancer Monoclonal Antibodies Market Research Report, the market was currently estimated to be at a USD 27 billion in 2015 and is poised to reach USD 45 billion by the end of 2020 with a CAGR of 11.2% from 2015 to 2020.